Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Breast Neoplasms 2Uterine Cervical Neoplasms 1Prostatic Neoplasms 1Multiple Myeloma 1Lymphoproliferative Disorders 1Lung Neoplasms 1Colorectal Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1Brain Neoplasms 1

Interventions

entrectinib 2atezolizumab 2alectinib 2venetoclax 1pertuzumab 1obinutuzumab 1ibrutinib 1etoposide phosphate 1enzalutamide 1cobimetinib 1capmatinib 1acalabrutinib 1Vincristine 1Vemurafenib 1Trastuzumab 1Specimen Handling 1Rituximab 1Radiotherapy 1Prednisone 1Positron-Emission Tomography 1Nivolumab 1Genetic Testing 1Genetic Counseling 1Follow-Up Studies 1Etoposide 1Doxorubicin 1Cyclophosphamide 1Chromatin Immunoprecipitation Sequencing 1CA-4948 1Biological Assay 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Lymphoproliferative Disorders × Follow-Up Studies × Clear all
NCT06630104 2026-01-08

Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)

Mayo Clinic

Phase NA Recruiting
82 enrolled
LymphoidPlasma cell

Lymphoproliferative Disorders, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡